Apolipoprotein L-I is positively associated with hyperglycemia and plasma triglycerides in CAD patients with low HDL
Apolipoprotein L-I (apoL-I) is present on a subset of HDL particles and is positively correlated with plasma triglycerides (TGs). We measured plasma apoL-I levels in coronary artery disease (CAD) subjects with low HDL who were enrolled in an angiographic CAD prevention trial. At baseline, apoL-I lev...
Main Authors: | Timothy S.E. Albert, Philippe N. Duchateau, Samir S. Deeb, Clive R. Pullinger, Min H. Cho, David C. Heilbron, Mary J. Malloy, John P. Kane, B. Greg Brown |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2005-03-01
|
Series: | Journal of Lipid Research |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0022227520340311 |
Similar Items
-
Randomized Comparative Study of the Effects of Treatment with Once-Daily, Niacin Extended-Release/Lovastatin and with Simvastatin on Lipid Profile and Fibrinolytic Parameters in Taiwan
by: Tsung-Hsien Lin, et al.
Published: (2006-06-01) -
Combinação de fármacos na abordagem das dislipidemias: associação entre estatinas e niacina Combination of drugs: statins and niacin
by: Jairo Lins Borges
Published: (2005-10-01) -
Genetic Variants Associated With Plasma Lipids Are Associated With the Lipid Response to Niacin
by: Sony Tuteja, et al.
Published: (2018-10-01) -
Differential effect of statin use on coagulation markers: an active comparative analysis in the NEO study
by: Mohammadreza Bordbar, et al.
Published: (2021-06-01) -
Current and Emerging Therapies for Atherosclerotic Cardiovascular Disease Risk Reduction in Hypertriglyceridemia
by: Reed Mszar, et al.
Published: (2023-02-01)